Nordling S - Search Results

1

Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis.

Lundin M, Nordling S, Roberts PJ, Lundin J, Carpelan-Holmström M, von Boguslawsky K, Haglund C. Lundin M, et al. Among authors: nordling s. Oncology. 1999 Jul;57(1):70-6. doi: 10.1159/000012003. Oncology. 1999. PMID: 10394128

2

The prognostic value of p27 in gastric cancer.

Wiksten JP, Lundin J, Nordling S, Kokkola A, von Boguslawski K, Haglund C. Wiksten JP, et al. Among authors: nordling s. Oncology. 2002;63(2):180-4. doi: 10.1159/000063813. Oncology. 2002. PMID: 12239454

3

Tenascin-C expression correlates with prognosis in gastric cancer.

Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K, Haglund C. Wiksten JP, et al. Among authors: nordling s. Oncology. 2003;64(3):245-50. doi: 10.1159/000069305. Oncology. 2003. PMID: 12697965

4

Prognostic value of syndecan-1 expression in breast cancer.

Leivonen M, Lundin J, Nordling S, von Boguslawski K, Haglund C. Leivonen M, et al. Among authors: nordling s. Oncology. 2004;67(1):11-8. doi: 10.1159/000080280. Oncology. 2004. PMID: 15459490

5

Syndecan-1 expression--a novel prognostic marker in pancreatic cancer.

Juuti A, Nordling S, Lundin J, Louhimo J, Haglund C. Juuti A, et al. Among authors: nordling s. Oncology. 2005;68(2-3):97-106. doi: 10.1159/000085702. Epub 2005 May 9. Oncology. 2005. PMID: 15886501

6

Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer.

Juuti A, Lundin J, Nordling S, Louhimo J, Haglund C. Juuti A, et al. Among authors: nordling s. Oncology. 2006;71(1-2):61-8. doi: 10.1159/000100988. Epub 2007 Mar 21. Oncology. 2006. PMID: 17377415

7

Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.

Haglund C, Lindgren J, Roberts PJ, Nordling S. Haglund C, et al. Among authors: nordling s. Br J Cancer. 1991 Mar;63(3):386-9. doi: 10.1038/bjc.1991.90. Br J Cancer. 1991. PMID: 1848439 Free PMC article.

8

Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.

Haglund C, Lindgren J, Roberts PJ, Kuusela P, Nordling S. Haglund C, et al. Among authors: nordling s. Br J Cancer. 1989 Dec;60(6):845-51. doi: 10.1038/bjc.1989.377. Br J Cancer. 1989. PMID: 2557879 Free PMC article.

9

Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer.

Victorzon M, Nordling S, Nilsson O, Roberts PJ, Haglund C. Victorzon M, et al. Among authors: nordling s. Int J Cancer. 1996 Jan 26;65(3):295-300. doi: 10.1002/(SICI)1097-0215(19960126)65:3<295::AID-IJC3>3.0.CO;2-V. Int J Cancer. 1996. PMID: 8575847

10

Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer.

Lundin J, Nordling S, von Boguslawsky K, Roberts PJ, Haglund C. Lundin J, et al. Among authors: nordling s. Oncology. 1996 Mar-Apr;53(2):104-11. doi: 10.1159/000227545. Oncology. 1996. PMID: 8604235

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters